ESC 365 - Doctor Karola Jering

Speaker illustration

Doctor Karola Jering

Brigham and Women's Hospital, Boston (United States of America)

Member of:

Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial

Event: ESC Congress 2024

Topic: Biomarkers

Session: Diagnostic and prognostic performance of cardiac troponin

Differences in risk profiles and clinical outcomes according to age in patients with high-risk myocardial infarction: insights from the PARADISE-MI trial

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Risk stratification models after acute coronary syndrome

Prognostic importance of NT-proBNP following high-risk myocardial infarction in the PARADISE-MI Trial

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Troponin and other biomarkers in acute coronary syndromes

Pulmonary hypertension in heart failure with preserved ejection fraction: the TOPCAT Americas and PARAGON-HF studies

Event: Heart Failure 2021

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure - Pathophysiology and Mechanisms 1

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources